MEDIZINREPORT
Stammzellforschung: Wie man eine Herzinsuffizienz verhindern will
Dtsch Arztebl 2011; 108(28-29): A-1576 / B-1336 / C-1332
| 1. | Wollert KC, Drexler H: Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat Rev Cardiol 2010; 7: 204–15. MEDLINE |
| 2. | Korf-Klingebiel M, et al.: Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J 2008; 29(23): 2851–8. MEDLINE |
| 3. | Korf-Klingebiel M, et al.: Conditional transgenic expression of fibroblast growth factor 9 in the adult mouse heart reduces heart failure mortality after myocardial infarction. Circulation 2011; 123: 504–14. MEDLINE |
| 4. | Wobus AM, et al.: Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation 1991; 48: 173–82. MEDLINE |
| 5. | Gupta MK, et al.: Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar. BMC Developmental Biology 2010; 10: 98. MEDLINE |
